GKB Ophthalmics (BOM:533212) Other Current Receivables: ₹10 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:533212 GKB Ophthalmics Ltd BOM:533212
54 GF Score
Price ₹61.90
GF Value ₹164.70
Valuation Significantly Undervalued
! 5 Warning Signs
View Full Analysis

What is GKB Ophthalmics Other Current Receivables?

GKB Ophthalmics BOM:533212 -3.21% 54 Other Current Receivables is ₹10 Mil as of Mar. 2026. GuruFocus rates BOM:533212 with a GF Score™ of 54/100 and a GF Value™ of ₹164.70 (Significantly Undervalued). The stock has 5 warning signs investors should review.

GKB Ophthalmics's Other Current Receivables for the quarter that ended in Mar. 2026 was ₹10 Mil.

GKB Ophthalmics's quarterly Other Current Receivables stayed the same from Sep. 2025 (₹0.00 Mil) to Dec. 2025 (₹0.00 Mil) but then increased from Dec. 2025 (₹0.00 Mil) to Mar. 2026 (₹9.70 Mil).

GKB Ophthalmics's annual Other Current Receivables increased from Mar. 2024 (₹1.58 Mil) to Mar. 2025 (₹3.38 Mil) and increased from Mar. 2025 (₹3.38 Mil) to Mar. 2026 (₹9.70 Mil).

GKB Ophthalmics Other Current Receivables Related Terms

GKB Ophthalmics Other Current Receivables Historical Data

* Premium members only.

The historical data trend for GKB Ophthalmics's Other Current Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

GKB Ophthalmics Other Current Receivables Chart

GKB Ophthalmics Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.22 11.47 1.58 3.38 9.70

GKB Ophthalmics Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.38 0.00 0.00 0.00 9.70
BOM:533212
54GF Score
GKB Ophthalmics Ltd BOM:533212
Other Current Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

GKB Ophthalmics Other Current Receivables Calculation

GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.

What does a Other Current Receivables of ₹10 Mil mean?
GKB Ophthalmics (BOM:533212) has a Other Current Receivables of ₹10 Mil as of Mar. 2026. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on GKB Ophthalmics and its competitors.
Is GKB Ophthalmics' Other Current Receivables too high?
GKB Ophthalmics' current Other Current Receivables is ₹10 Mil. Overall, GKB Ophthalmics has a GF Score™ of 54/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does GKB Ophthalmics' Other Current Receivables compare to ISRG and BDX?
GKB Ophthalmics' Other Current Receivables of ₹10 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Receivables for a Medical Devices & Instruments company?
A good Other Current Receivables depends on the Medical Devices & Instruments industry context. However, Other Current Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Receivables mean?
A high Other Current Receivables can signal that a stock is expensive relative to its fundamentals. Other Current Receivables is other current receivables of that not otherwise classified. View historical data on GKB Ophthalmics and its competitors. GKB Ophthalmics's current Other Current Receivables is ₹10 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is GKB Ophthalmics stock overvalued right now?
Based on GuruFocus' analysis, GKB Ophthalmics (BOM:533212) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹164.70, compared to a current price of ₹61.90 — trading 62.4% below its estimated fair value. The current Other Current Receivables is ₹10 Mil. GKB Ophthalmics' overall GF Score™ is 54/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Receivables calculated?
Other Current Receivables is calculated from a company's financial statements. For GKB Ophthalmics (BOM:533212), the current Other Current Receivables is ₹10 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is GKB Ophthalmics (BOM:533212) Overvalued in 2026?

Based on GuruFocus' analysis, GKB Ophthalmics stock appears to be undervalued. The current stock price of ₹61.90 is trading 62.4% below its estimated GF Value™ of ₹164.70. GuruFocus considers GKB Ophthalmics to be Significantly Undervalued.

Key valuation signals for BOM:533212:

  • Other Current Receivables: ₹10 Mil
  • GF Value™: ₹164.70 vs. price of ₹61.90 (62.4% below fair value)
  • GF Score™: 54/100 with 5 warning signs

No single metric tells the full story. See the BOM:533212 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

GKB Ophthalmics Business Description

Address 16-A, Tivim Industrial Estate, Mapusa, GA, IND, 403 526
GKB Ophthalmics Ltd is an India-based company engaged in manufacturing and exporting ophthalmics lenses. It manufactures glass and plastic lenses both semi-finished and finished forms. The other products of the company include Organic lenses, Glass moulds, and Bifocal moulds. The company sells its products in India and also exports globally. Geographically, the majority of its revenue is generated from outside of India.
54GF Score

Get the complete analysis for BOM:533212

Other Current Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹61.90
Price
₹164.70
GF Value